<P>PART I INTRODUCTION.- Laboratory Aspects of Medical Mycology.- Epidemiology of Systemic Fungal Diseases: Overview.- PART II SYSTEMIC ANTIFUNGAL DRUGS.- Amphotericin B.- Liposomal Nystatin.- Flucytosine.- Azole Antifungal Drugs.- Cell Wall Synthesis Inhibitors: Echinocandins and Nikkomycins.- Terbinafine.- Resistance to Antifungal Drugs.- Adjunctive Antifungal Therapy.- PART III MYCOSES CAUSED BY YEASTS.- Candidiasis.- Cryptococcosis.- Rhodotorula, Malassezia, Trichosporon, and Other Yeast-Like Fungi.- PART IV MYCOSES CAUSED BY MOULDS.- Aspergillosis.- Zygomycoses.- Hyalohyphomycoses (other than Aspergillosis and Penicilliosis).- Phaeohyphomycoses.- PART V MYCOSES CAUSED BY DIMORPHIC FUNGI.- Histoplasmosis.- Blastomycosis.- Coccidioidomycosis.- Paracoccidioidomycosis.- Sporotrichosis.- Penicilliosis.- PART VI MYCOLOGY INVOLVING SKIN AND SUBCUTANEOUS TISSUES.- Superficial Cutaneous Fungal Infections.- Eumycetoma.- Chromoblastomycosis.- PART VII OTHER MYCOSES.- Pneumocystosis.- Miscellaneous Fungi.- PART VIII SPECIAL PATIENT POPULATIONS.- Fungal Infections in Neutropenic Patients.- Fungal Infections in Blood and Marrow Transplant Recipients.- Fungal Infections in Solid Organ Transplant Recipients.- Fungal Infections among Patients with AIDS.</P>